arrow
N

Nicole Trainor

imperial college london
H指数:18
被引数:2,209

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Expanding the toolbox to develop IAP-based degraders of TEAD transcription factors
2026-01-190
OA
Discovery of Potent Orally Active Plasmodium N -Myristoyltransferase Inhibitors Using Fragment-Linking Approaches

利用片段连接方法发现强效、口服活性的疟原虫N-十四酰基转移酶抑制剂

2026-01-010
OA
Identification of a Highly Cooperative PROTAC Degrader Targeting GTP-Loaded KRAS(On) Alleles

鉴定一种靶向结合GTP的KRAS(On)等位基因的高度协同作用的PROTAC降解剂

2025-10-300
OAAI
Frustration in the protein-protein interface plays a central role in the cooperativity of PROTAC ternary complexes

蛋白质-蛋白质界面上的 frustration 在PROTAC三元复合物的协同性中起着核心作用。

2025-09-290
OAAI
Confounding Factors in Targeted Degradation of Short-Lived Proteins
2024-07-0312
OA
A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo
2022-10-1099
OAAI
BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design (vol 15, pg 672, 2019)
2019-07-0211
OAAI
Structure-based PROTAC design demonstrates BAF complex ATPase vulnerabilities in cancer
2019-07-011
PRE
BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design
2019-06-10381
OAAI
Highly Selective PTK2 Proteolysis Targeting Chimeras to Probe Focal Adhesion Kinase Scaffolding Functions
2019-02-09106
OAAI
P2-Quinazolinones and Bis-Macrocycles as New Templates for Next-Generation Hepatitis C Virus NS3/4a Protease Inhibitors: Discovery of MK-2748 and MK-6325
2015-03-1021
PREAI
Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor
2012-03-02160
OA
Discovery of 3-Substituted Aminocyclopentanes as Potent and Orally Bioavailable NR2B Subtype-Selective NMDA Antagonists
2011-06-2037
OA
Discovery of MK-1220: A Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma Exposure
2011-01-1237
OAAI
MK-5172: A NOVEL HCV NS3/4A PROTEASE INHIBITOR WITH POTENT ACTIVITY AGAINST KNOWN RESISTANCE MUTANTS
2010-04-012
PREAI
Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor
2010-02-17157
PREAI